X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
male (29) 29
female (25) 25
middle aged (20) 20
aged (18) 18
oncology (16) 16
index medicus (14) 14
medicine & public health (14) 14
adult (13) 13
gastroenterology & hepatology (10) 10
neuroendocrine tumors (10) 10
endocrinology & metabolism (9) 9
pancreatic neoplasms - pathology (9) 9
surgery (9) 9
tumors (9) 9
animals (8) 8
cancer (8) 8
diagnosis (8) 8
gastrinoma - diagnosis (8) 8
immunohistochemistry (8) 8
management (8) 8
pancreatic neoplasms - diagnosis (8) 8
abdominal surgery (7) 7
injection test (7) 7
japan (7) 7
mutation (7) 7
reverse transcriptase polymerase chain reaction (7) 7
endocrine tumors (6) 6
esophageal neoplasms - pathology (6) 6
expression (6) 6
gastrinoma - surgery (6) 6
gastroenterology (6) 6
gene expression (6) 6
japan - epidemiology (6) 6
neuroendocrine tumor (6) 6
pancreas (6) 6
pancreatic neoplasms - drug therapy (6) 6
prognostic-factors (6) 6
rats (6) 6
rna, messenger - metabolism (6) 6
surgical oncology (6) 6
treatment outcome (6) 6
zollinger-ellison syndrome (6) 6
colorectal surgery (5) 5
epidemiology (5) 5
hepatology (5) 5
insulinoma (5) 5
multiple endocrine neoplasia type 1 (5) 5
neuroendocrine tumors - diagnosis (5) 5
neuroendocrine tumors - drug therapy (5) 5
neuroendocrine tumors - pathology (5) 5
pancreatic neoplasms - metabolism (5) 5
prognosis (5) 5
adolescent (4) 4
analysis (4) 4
cardiac surgery (4) 4
chemotherapy (4) 4
child (4) 4
cyclooxygenase 2 (4) 4
diagnosis, differential (4) 4
dimethylnitrosamine - analogs & derivatives (4) 4
esophageal neoplasms - chemically induced (4) 4
esophageal neoplasms - prevention & control (4) 4
gastrinoma (4) 4
general surgery (4) 4
guidelines (4) 4
localization (4) 4
medical colleges (4) 4
metastasis (4) 4
multiple endocrine neoplasia type 1 - diagnosis (4) 4
multiple endocrine neoplasia type 1 - epidemiology (4) 4
neuroendocrine tumors - epidemiology (4) 4
pancreatic neoplasms - surgery (4) 4
rats, inbred f344 (4) 4
research (4) 4
secretin (4) 4
secretion (4) 4
survival (4) 4
thoracic surgery (4) 4
vascular surgery (4) 4
calcium-sensing receptor (3) 3
carcinogenesis (3) 3
carcinoid-tumors (3) 3
carcinoma (3) 3
carcinoma, squamous cell - pathology (3) 3
cloned cdna (3) 3
curative resection (3) 3
cyclooxygenase 1 (3) 3
cyclooxygenase-2 (3) 3
diabetes (3) 3
dinoprostone - metabolism (3) 3
disease models, animal (3) 3
disease-free survival (3) 3
duodenum (3) 3
endocrine neoplasia type-1 (3) 3
endocrine tumor (3) 3
enzyme-linked immunosorbent assay (3) 3
esophageal neoplasms - enzymology (3) 3
esophageal neoplasms - metabolism (3) 3
fixed constructions (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 2/2010, Volume 45, Issue 2, pp. 234 - 243
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4625 - 4632
Journal Article
Journal of Japanese Society of Gastroenterology, ISSN 0446-6586, 12/2014, Volume 111, Issue 12, pp. 2263 - 2271
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2017, Volume 35, Issue 4, pp. 499 - 508
Background Lanreotide is a long-acting somatostatin analog with demonstrated efficacy against enteropancreatic neuroendocrine tumor (NET) in the phase III... 
Medicine & Public Health | Lanreotide | Oncology | Phase II | Pharmacology/Toxicology | Neuroendocrine tumor | Japanese | Somatostatin analog | ONCOLOGY | ANALOGS | PHARMACOLOGY & PHARMACY | SOMATOSTATIN RECEPTORS | Pancreatic Neoplasms - metabolism | Somatostatin - adverse effects | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Pancreatic Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Gastrointestinal Neoplasms - metabolism | Somatostatin - analogs & derivatives | Gels | Neuroendocrine Tumors - metabolism | Kaplan-Meier Estimate | Treatment Outcome | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Peptides, Cyclic - blood | Disease-Free Survival | Asian Continental Ancestry Group | Somatostatin - blood | Antineoplastic Agents - blood | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Aged | Somatostatin - therapeutic use | Peptides, Cyclic - adverse effects | Complications and side effects | Dosage and administration | Somatostatin | Research | Fas antigen | Midgut | Hindgut | Diabetes mellitus | Pharmacology | Injection | Patients | Survival | Metastases | Confidence intervals | Studies | Lungs | Multiple endocrine neoplasia | Safety | Feces | Pancreas | Pharmacokinetics | Foregut | Tumors | Neuroendocrine tumors | Phase II Studies
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 04/2012, Volume 76, Issue 4, pp. 533 - 539
Journal Article
Pancreas, ISSN 0885-3177, 07/2009, Volume 38, Issue 5, pp. 491 - 492
Journal Article
Pancreatology, ISSN 1424-3903, 2016, Volume 16, Issue 4, pp. S55 - S56
  Univariate analyses revealed that distant metastases and the high Ki-67 index were risk factors for disease-specific death. 
Endocrinology & Metabolism | Gastroenterology and Hepatology | Risk factors
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2018, Volume 82, Issue 4, pp. 661 - 668
Journal Article